| 摘要: |
| ［摘要］ 目的 探讨自体造血干细胞移植（auto-HSCT）治疗合并乙型肝炎病毒（HBV）感染的弥漫大B细胞淋巴瘤（DLBCL）患者的有效性、安全性和生存获益。方法 回顾性分析2008年8月至2020年8月于北京大学肿瘤医院接受auto-HSCT治疗的39例初治合并HBV感染的DLBCL患者资料，采用Kaplan-Meier生存曲线进行生存分析。结果 全组患者移植前后的完全缓解率分别为56.41%和71.79%，移植后3年无进展生存率及总生存率分别为38.46%和58.97%，39例患者均获得造血重建。结论 auto-HSCT用于治疗合并HBV感染的DLBCL是安全有效的，可明显改善患者预后。 |
| 关键词: 自体造血干细胞移植 乙型肝炎病毒 弥漫大B细胞淋巴瘤 预后 |
| DOI：10.3969/j.issn.1674-3806.2023.11.02 |
| 分类号:R 733.4 |
| 基金项目:北京市卫生健康科技成果和适宜技术推广项目（编号：BHTPP2022058）；希思科-豪森肿瘤研究基金项目（编号：Y-HS202202-0104） |
|
| Analysis of the effectiveness and safety of autologous hematopoietic stem cell transplantation in treatment of diffuse large B-cell lymphoma patients complicated with hepatitis B virus infection |
|
WANG Yue, CHEN Jie, Reyizha Nuersulitan, et al.
|
|
Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China
|
| Abstract: |
| ［Abstract］ Objective To explore the effectiveness and safety of autologous hematopoietic stem cell transplantation(auto-HSCT) in treatment of diffuse large B-cell lymphoma(DLBCL) patients complicated with hepatitis B virus(HBV) infection and the benefits of auto-HSCT for the patients′ survival. Methods The data of 39 DLBCL patients complicated with HBV infection who were newly treated with auto-HSCT in Peking University Cancer Hospital from August 2008 to August 2020 were retrospectively analyzed, and Kaplan-Meier(KM) curve was used for survival analysis. Results The complete remission rates of all the included patients before and after auto-HSCT were 56.41% and 71.79%, respectively. The 3-year progression-free survival and overall survival rates after auto-HSCT were 38.46% and 58.97%, respectively. Hematopoietic reconstruction was achieved in all the 39 patients. Conclusion auto-HSCT is safe and effective in treatment of the DLBCL patients complicated with HBV infection, and can significantly improve the prognosis of the patients. |
| Key words: Autologous hematopoietic stem cell transplantation(auto-HSCT) Hepatitis B virus(HBV) Diffuse large B-cell lymphoma(DLBCL) Prognosis |
